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ABSTRACT 
Objective: To assess the influence of pharmacist mediated education on medication adherence behavior (MMAS-8) in rural patients with type 2 
diabetes mellitus. 
Methods: This is a prospective, randomized interventional study approved by the institutional ethics committee. Eligible type 2 diabetic patients 
with written informed consent were enrolled and randomized into control and test group. The MMAS-8 questionnaire was administered to all 
patients at baseline and three subsequent follow-ups. Patients in the test group received structured education at every follow-up, whereas the 
control group patients received education only at the final follow up. SPSS software was used to evaluate the data.  
Results: Among the 72 patients enrolled, 35 were randomized into a control group and 37 into the test group. Majority of the study patients 
(65.2%) were males with an age range of 30 to 72 y and were from agriculture profession (34.72%) with school education (59.7%). The mean body 
mass index (BMI) of the study patients was 25.01. At baseline, the mean glycosylated hemoglobin (HbA1c) value of patients was 6.48±1.39% in the 
control group and 6.23±1.16% in the test group. During the last follow-up, a significant (p<0.05) improvement was observed in MMAS-8 scores in 
test group patients compared to control group patients which were supported by statistically significant (p<0.05) improvement in capillary blood 
glucose (CBG) values.  
Conclusion: Pharmacist mediated structured education has shown a positive impact on medication adherence behavior of test group patients 
towards their disease management. 
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Diabetes mellitus (DM) is a metabolic disorder characterized by 
hyperglycemia. Increasing at an alarming pace particularly in 
developing countries [1] and it is estimated that, globally about 382 
million people are suffering from diabetes [2]. According to the 
World Health Organisation (WHO), diabetes will be the 7th leading 
cause for death in 2030 [3]. The global expenditure due to diabetes 
is estimated to be 548 US billion dollars and in India, it is estimated 
to be 6 billion US dollars and the mortality rate is about 55% [2]. 
Patient’s poor knowledge on the disease and its management and 
medication non-adherence lead to inadequate management of 
diabetes. Studies have confirmed about the positive influence of 
pharmacist mediated education on knowledge, attitude, and 
practices about disease and therapy which has shown a positive 
impact on health-related quality of life [4, 5]. 
Patient education is the most effective way to improvise patient 
responsibility towards disease management and minimize the 
diabetes complications and improve the outcomes [6]. This 
corroborates the importance of awareness among diabetics in DM 
management.  
Research evidence available are suggesting the influence of 
pharmacist mediated patient education in improving medication 
adherence and good glycaemic control along with reduced diabetes-
related complications [7]. 
Medication adherence is defined as the extent to which a patient’s 
medication-taking behavior coincides with the intention of the 
health advice he or she has been given. It is the most important 
factor that determines therapeutic outcomes, especially in patients 
suffering from a chronic illness like diabetes mellitus. The 
pharmacist can contribute and play a major role in the assessment of 
patients understanding about the illness and the therapy and 
communicate the benefits of treatment and assess the patient’s 
readiness for the care plan and discuss any barriers to adherence 
that patients may have [8, 9].  
Many studies have suggested that pharmacist role in medication 
adherence has a significant positive impact on health outcomes. A 
systemic review of the literature on the role of the pharmacist 
suggested that a potential benefit of pharmacist interventions was 
observed in improving medication adherence behavior in diabetes, 
especially through patient education. 
A study conducted by R Adepu et al. that assessed the medication 
adherence behavior using Brief Medication Questionnaire (BMQ) 
and adherence risk scale (ARS) in type 2 DM patients receiving 
pharmacist mediated structured education demonstrated a 
significant improvement in medication adherence and final CBG 
values (*p = 0.003) [10]. 
Another systematic review by Sujatha Sapkota et al. including 52 
studies discussing medication adherence behavior in type 2 DM 
patients reported improvement in adherence to anti-diabetic 
medications in 22 interventions and nine interventions showed 
improvement in anti-diabetic medication adherence as well as 
glycaemic control [11]. 
MATERIALS AND METHODS 
Methodology  
This is a prospective interventional study conducted in medicine 
outpatient department of Adichunchanagiri Hospital and Research 
Centre, Mandya, Karnataka, India, over a period of 6 mo. Type 2 DM 
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patients of both genders meeting the inclusion criteria were enrolled 
in the study using block randomization technique to avoid selection 
bias. Type 2 diabetes mellitus patients with disease duration of less 
than 3 y were included.  
Paediatric, gestational diabetes and psychiatric patients were 
excluded from the study.  
This study was approved by the institutional human ethics 
committee and issued a letter to conduct the study AIMS/IEC/1910. 
Prior to initiating the study, the knowledge level of the surrounding 
community helps in selecting appropriate population and the level 
of awareness to be provided can be known. 
A suitably designed data collection form was developed, details like 
patient demographics, educational status, social habits, 
socioeconomic status, past medical history and past medication 
history, family history, allergies, BMI, diet, marital status, smoking 
and alcohol status were obtained.  
Morisky Medication Adherence Scale (MMAS-8) 8 item questionnaire 
was administered at baseline to assess the medication adherence 
behavior. The questionnaire assesses various areas of medication 
adherence behavior. There are a total of 8 questions, with a range from 
0 to 8 [12-14]. This questionnaire was completed by the patient or 
patient attender at face to face interview with the investigator.  
HbA1c was performed at baseline to assess the diabetic status of the 
enrolled patients. All the enrolled patients were followed for 3 mo 
from baseline with an interval of 30 d between the follow-ups. At 
every follow-up visit, BP and CBG were recorded that is fasting blood 
sugar (FBS) and postprandial blood sugar (PPBS). Test group 
patients received the pharmacist mediated structured education 
regarding the disease, medication, diet, and lifestyle modification at 
baseline and further follow-ups and received patient information 
leaflet. The control group patients received detailed education only 
at the final follow-up visit.  
Statistical analysis 
Results were analysed using Statistical Package for the Social 
Sciences (SPSS) for Windows Version 20. The significance of the 
change in CBG at each follow-up visit compared to first follow-up 
was assessed using independent t-test. The significance of the 
change in MMAS 8 scores from baseline to final follow-up was also 
assessed using a paired t-test. p value of<0.05 is considered as 
significant. 
RESULTS 
A total of 72 eligible type 2 DM patients meeting the inclusion 
criteria were enrolled into the study. These patients were 
randomized into control and test group, 35 patients were from the 
control group and 37 patients were from the test group. 65.27% 
were males and 34.73% were females. The minimum age of the 
patients was 30 y and maximum age of the patients was 72 y. The 
mean (±SD) age of test group patients was 51.29±10.82 y and that of 
the control group patients was 58.05±12.75 y. The majority of the 
enrolled patients were literate (79.16%), with most of the patients 
having completed primary schooling education (59.7 %), who were 
farmers, daily wage laborers, and small business by profession since 
they belonged to the rural population.  
The demographic details of the patients who had completed all the 
follow-ups are presented in table 1. 
 
Table 1: Demographic characteristics 
Parameter Control (n=35) Test (n=37) p value (<0.05) 
Gender No % No %  
• Male 18 25 29 40.27 0.937 
• Female 17 23.6 8 11.1 
Age      
0.813 • 30-40 4 5.5 8 11.1 
• 41-50 8 11.1 10 13.8 
• 51-60 9 12.5 10 13.8 
• 61 and above 14 19.4 9 12.5 
Educational qualification      
0.866 • Illiterate 11 15.2 4 5.5 
• Primary school 11 15.2 9 12.5 
• Secondary school 9 12.5 13 18.05 
• PUC 3 4.1 4 5.5 
• Graduate 0 0 6 8.3 
• Post Graduate 1 1.3 1 1.3 
Profession      
0.900 • Agriculture 14 19.4 11 15.2 
• Business 4 5.5 12 9.72 
• Employment 2 2.7 7 9.72 
• Housewife 15 20.8 7 9.72 
Smoking status       
0.844 Yes 2 2.7 7 9.72 
No 33 45.8 30 41.6 
Alcoholic status       
0.874 Yes 7 9.72 13 18.05 
No 28 38.8 24 33.3 
 
The mean BMI of the male patients was 24.76% and female patients 
were 25.27%. Majority of the patients (62.5%) had an average 
annual income of Rs. 50,000 to Rs. 1,00,000 and the rest of the 
patients were homemakers. The percentage of smokers in the 
control group and test groups were 11% and 24% respectively. 
Alcoholic status of patients in the control group was 39%, and the 
test group was 45%.  
At baseline HbA1c test was conducted to know the diabetic status of 
the enrolled patients. The mean HbA1c value was 6.48±1.39% in the 
control group patients and 6.23±1.16% in the test group patients.  
At First follow-up and subsequent follow-ups, CBG for FBS and PPBS 
was monitored to assess the influence of educational intervention on 
medication adherence behavior and glycaemic control. In the control 
group at the first follow-up, the mean FBS was 133 mg/dl and mean 
PPBS was 180 mg/dl. In the final follow-up, the mean FBS was 132 
mg/dl and the mean PPBS was 175 mg/dl. These values suggest that 
the glycaemic control did not change in the control group patients. 
Whereas the mean FBS during the first follow-up in test group patients 
was 123 mg/dl and mean PPBS was 175 mg/dl. In the final follow-up, 
the mean FBS was 105 mg/dl, and the mean PPBS was 133 mg/dl. 
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Fig. 1: Mean fasting blood sugar and mean postprandial blood sugar in control group 
 
 
Fig. 2: Mean fasting blood sugar and mean postprandial blood sugar in the test group 
 
Medication adherence behavior is the important predictor in the 
disease management. In subjective testing, MMAS-8 is a validated 
tool to assess the medication adherence behavior in the patients. In 
the control group at baseline mean HbA1c was 6.48±1.39%, mean 
MMAS-8 score at baseline was 4.39 and by the end of the final 
follow-up mean MMAS-8 score was 4.9. 
In the test, mean group HbA1c was 6.23±1.16%, mean MMAS-8 
score was 4.26 at baseline, and by the end of the final follow-up, it 
was increased to 7.89. Similarly, mean FBS and PPBS values in 
control group at first follow-up were 133 mg/dl and 180 mg/dl 
respectively, at final follow-up were 132 mg/dl and 175 mg/dl 
respectively. In the test group mean FBS and PPBS at first follow-up 
was 123 mg/dl and 175 mg/dl respectively, and at final follow-up 
was 105 mg/dl and 133 mg/dl respectively. This clearly states that 
educational intervention had a significant impact from baseline to 
final follow-up with the objective evidence through HbA1c values 
and CBG values and subjective evidence through the MMAS-8 scores 
of control and test group. Thus it is clear that medication adherence 
behavior had a significant impact on test group patients with 
structured patient education.  
In control group patients the mean MMAS-8 score in the baseline 
was 4.26, the first follow-up was 4.42, second follow-up was 4.57, 
and third follow-up was 4.90. Whereas in the test group patients 
mean MMAS-8 score in the baseline was 4.39, first follow-up was 
6.12, the second follow-up was 7.31 and third follow-up was 7.89. A 
significant improvement was seen in test group patients (p<0.05) in 
MMAS-8 scores. The findings of MMAS-8 scores of both control and 
test group are presented in fig. 3. 
  
 
Fig. 3: Morisky medication adherence scores1, 1use of the ©MMAS is protected by US copyright laws. Permission for use is required. A 
license agreement is available from Donald E. Morisky, 294 Lindura Court, Las Vegas, NV 89138-4632; dmorisky@gmail. com 
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Diabetes is a chronic disease and important public health problem 
nationally, internationally and the global prevalence of diabetes is on 
the rise. Inadequate management of diabetes leads to several health 
problems with increased risk of complications. This is mainly 
associated with the patient’s poor knowledge about the disease and 
its management. Pharmacists by virtue of their professional status 
act as a liaison between the clinicians and patients not only by 
dispensing the prescribed medications but also assists the patients 
in the safe use of prescribed medicines and thereby enhancing their 
medication adherence behavior and thereby improving the health-
related quality of life.  
A total of 72 patients were included in the study. Males (65.2%) 
outnumbered females (34.73%), and a maximum number of patients 
23 (31.9%) were in the age group of 61 and above, which is similar 
to the study conducted by K V Ramnath et al. [15]. 
Literacy rate in our study was 57 (79.16%) patients which eased 
structured patient counselling with the usage of patient information 
leaflet (PIL), as they could recall the information reading PIL at 
home, which was similar to the study conducted by Malathy R et al., 
Adepu R et al. and K V Ramnath et al. [5, 10, 15-17].  
Medication nonadherence is another multifaceted problem 
especially for chronic diseases which plays an important role in 
determining the therapeutic outcomes. Studies have confirmed 
about the positive influence of pharmacist mediated education on 
knowledge, attitude, and practices about the disease and therapy 
which has shown a positive impact on medication adherence 
behaviour and positive health-related quality of life [4].  
Patients with family history of diabetes were much aware of the role 
and responsibility in keeping their glycaemic status under control 
through proper diet, medication adherence and lifestyle 
modifications, with 26 (36.11%) of patients having a family history 
of DM. A study conducted by Shobana et al. showed similar results. 
Similarly, educational status had a positive impact [18]. 
It is surprising to see 47 (63.8%) of the patients have no family 
history of diabetes and were in the age group of 40-60 y. This 
probably indicates diabetes is emerging rapidly in the general 
population with various habits like increased intake of fats, high-
calorie diet, beverages, cool drinks and junk food. A sedentary 
lifestyle with least or no exercise/physical activity, stressful, 
challenging corporate lifestyle with increased job demands, social 
status. Current younger generation possesses a greater risk due to 
stressful and sedentary lifestyle.  
Nine (12.5%) patients in our study were smokers and 20 (27.7%) 
were alcoholic which has adverse effects on diabetes. Majority of the 
patients were neither alcoholic nor smokers which decreased the 
risk of complications, which was similar to the study conducted by K 
V Ramanath et al. [17].  
Diabetic patients often develop complications due to inadequate 
glycaemic control mainly because of poor practices regarding the 
disease and management [5]. Patient education is the most effective 
way to improvise patient’s responsibility towards disease 
management and minimize the diabetes complications and improve 
the health outcomes. Diabetic patients who wish to lead a normal life 
should understand about their illness and the strategies to put the 
disease under control [6]. This corroborates the importance of 
awareness among diabetics on DM management.  
Medication adherence is a key element in the whole disease 
management process. Many predictors will influence the adherence 
behavior in patients. One among them is knowledge about the disease 
and the key role of medicines in its management. If patients are well 
informed about these, certainly they will take the responsibility of 
managing their disease through improved medication adherence 
behaviour. In the present study, a significant improvement in the 
medication adherence behaviour is observed in test group patients 
(p<0.05). Adherence behaviour will reflect on health outcomes that 
can be vouched by FBS and PPBS values. In the study, population 
adherence behaviour was significantly improved in test group patients 
due to pharmacist mediated intervention. The healthcare provider 
support in improving the medication adherence behavior is 
corroborated by many research studies. In a study conducted by R 
Grant et al. in a type 2 DM cohort found that improved medication 
adherence behavior in patients kept their HbA1c levels under control 
compared to the non-adherent patients [19]. In a meta-analysis of 
medication adherence behavior studies conducted by Sapkota S, Brien 
J-a et al. observed that educational intervention has shown a 
significant role in medication adherence behavior in diabetes patients 
in various research studies conducted globally. These findings 
strengthened the need of pharmacist mediated educational 
intervention in removing the inertia of medication nonadherence in 
type 2 DM patients [11]. The findings in our study also showed a 
statistically significant improvement in the Morisky Medication 
Adherence scores in test group patients compared to the patients in 
the control group. The findings of the study are a clear indication 
showing the importance of educational intervention in patients with 
chronic diseases such as diabetes. 
A strict adherence to medication will improve the desired clinical 
outcomes such as glycaemic control in diabetes patients. This, in 
turn, will improve the health-related quality of life in diabetes 
patients. A healthy individual demonstrates productivity and 
satisfaction in the life.  
CONCLUSION 
Diabetes is a chronic disorder affects the social and emotional well-
being of the patients if the glycaemic control is not adequately 
maintained. A structured education empowers the patients to take 
responsibility in adhering to their prescribed medication and 
thereby achieving the desired clinical outcomes. From the findings of 
our study, it can be concluded that structured education to patients 
in test group by a pharmacist has shown a significant improvement 
in medication adherence behavior, supporting the interventional 
educational role of the pharmacist. 
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